Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
GROW Funds LLC ended 2025 with strong performance, with managed portfolios delivering net returns between +7% and +23%, and its accredited-only hedge fund up approximately 175% net of fees. The firm highlighted...
— Mike Collins, Matt Clarke, Chase McIntosh, Carl Wiese
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Axsome Therapeutics, Inc.
No other institutional pitches found for this ticker yet.